Evercore Trust Company N.A. Takes Position in Danaher Co. (NYSE:DHR)

Evercore Trust Company N.A. purchased a new position in shares of Danaher Co. (NYSE:DHR) in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 1,324,386 shares of the conglomerate’s stock, valued at approximately $113,606,000. Danaher makes up 0.3% of Evercore Trust Company N.A.’s investment portfolio, making the stock its 26th biggest position. Evercore Trust Company N.A. owned approximately 0.19% of Danaher as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds have also recently modified their holdings of DHR. BlackRock Inc. lifted its stake in shares of Danaher by 2,530.9% in the 1st quarter. BlackRock Inc. now owns 37,967,922 shares of the conglomerate’s stock valued at $3,247,398,000 after purchasing an additional 36,524,795 shares during the last quarter. Flossbach Von Storch AG lifted its stake in Danaher by 44.7% during the 2nd quarter. Flossbach Von Storch AG now owns 5,782,019 shares of the conglomerate’s stock worth $487,945,000 after acquiring an additional 1,785,810 shares in the last quarter. Arrowstreet Capital Limited Partnership lifted its stake in Danaher by 16,410.0% during the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 1,485,901 shares of the conglomerate’s stock worth $125,395,000 after acquiring an additional 1,476,901 shares in the last quarter. Findlay Park Partners LLP lifted its stake in Danaher by 52.9% during the 3rd quarter. Findlay Park Partners LLP now owns 4,117,348 shares of the conglomerate’s stock worth $353,186,000 after acquiring an additional 1,425,000 shares in the last quarter. Finally, Koch Industries Inc. lifted its stake in Danaher by 29,127.3% during the 2nd quarter. Koch Industries Inc. now owns 1,404,665 shares of the conglomerate’s stock worth $1,388,000 after acquiring an additional 1,399,859 shares in the last quarter. Hedge funds and other institutional investors own 76.05% of the company’s stock.

Several brokerages have weighed in on DHR. JPMorgan Chase & Co. restated an “overweight” rating and set a $95.00 price target on shares of Danaher in a report on Friday, September 8th. Zacks Investment Research upgraded Danaher from a “hold” rating to a “buy” rating and set a $97.00 price target on the stock in a report on Thursday, October 5th. Morgan Stanley reiterated an “overweight” rating and issued a $95.00 price objective (up previously from $86.00) on shares of Danaher in a report on Friday, October 6th. Credit Suisse Group reiterated a “hold” rating and issued a $99.00 price objective on shares of Danaher in a report on Tuesday, December 19th. Finally, Cowen reissued a “buy” rating and issued a $90.00 target price on shares of Danaher in a research report on Wednesday, October 4th. One investment analyst has rated the stock with a sell rating, six have given a hold rating, ten have issued a buy rating and one has assigned a strong buy rating to the stock. The company has a consensus rating of “Buy” and a consensus target price of $94.38.

In related news, SVP Daniel Raskas sold 37,870 shares of Danaher stock in a transaction on Thursday, November 16th. The stock was sold at an average price of $93.33, for a total value of $3,534,407.10. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Donald J. Ehrlich sold 10,578 shares of Danaher stock in a transaction on Tuesday, October 24th. The shares were sold at an average price of $90.82, for a total value of $960,693.96. Following the completion of the transaction, the director now owns 104,621 shares in the company, valued at approximately $9,501,679.22. The disclosure for this sale can be found here. In the last ninety days, insiders sold 273,810 shares of company stock valued at $25,218,813. Company insiders own 12.20% of the company’s stock.

Danaher Co. (NYSE:DHR) traded down $0.74 during midday trading on Friday, reaching $92.82. The company had a trading volume of 1,844,786 shares, compared to its average volume of 2,109,975. Danaher Co. has a 12-month low of $77.66 and a 12-month high of $95.16. The stock has a market cap of $65,080.82, a P/E ratio of 27.38, a P/E/G ratio of 2.21 and a beta of 1.02. The company has a quick ratio of 1.00, a current ratio of 1.43 and a debt-to-equity ratio of 0.42.

Danaher (NYSE:DHR) last released its quarterly earnings results on Thursday, October 19th. The conglomerate reported $1.00 earnings per share for the quarter, topping the consensus estimate of $0.95 by $0.05. The company had revenue of $4.53 billion during the quarter, compared to the consensus estimate of $4.47 billion. Danaher had a return on equity of 11.29% and a net margin of 13.36%. Danaher’s revenue was up 9.6% compared to the same quarter last year. During the same quarter last year, the business posted $0.87 earnings per share. equities research analysts anticipate that Danaher Co. will post 3.99 earnings per share for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, January 26th. Stockholders of record on Friday, December 29th will be given a $0.14 dividend. This represents a $0.56 dividend on an annualized basis and a dividend yield of 0.60%. The ex-dividend date is Thursday, December 28th. Danaher’s dividend payout ratio is currently 16.52%.

ILLEGAL ACTIVITY WARNING: This news story was published by Week Herald and is the sole property of of Week Herald. If you are accessing this news story on another domain, it was stolen and reposted in violation of United States & international trademark and copyright law. The original version of this news story can be viewed at https://weekherald.com/2017/12/30/evercore-trust-company-n-a-buys-new-stake-in-danaher-corporation-dhr.html.

Danaher Company Profile

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply